Company Filing History:
Years Active: 2022
Title: The Innovations of Xing Chen: A Pioneer in Dihydropyrimidine Compounds
Introduction: Xing Chen, an accomplished inventor based in Chengdu, China, has made significant contributions to the field of pharmaceuticals. With one patent to his name, Chen specializes in the development of a solid form of dihydropyrimidine compound, showcasing his innovative prowess in drug formulation and applications.
Latest Patents: Xing Chen holds a patent titled "Solid form of dihydropyrimidine compound and preparation method therefor and use thereof." This invention focuses on a solid form of the compound (E)-3-((R)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)acrylic acid). It details a preparation method and discusses its pharmaceutical applications, particularly in formulating drugs aimed at preventing or treating viral diseases. Chen’s work is a testament to his dedication to advancing medicinal chemistry and therapeutic options.
Career Highlights: Currently, Xing Chen is affiliated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Here, he plays a crucial role in research and development, contributing to projects that push the boundaries of pharmaceutical science. His work exemplifies a commitment to innovation and technological advancement in the biopharmaceutical sector.
Collaborations: In his professional journey, Chen collaborates closely with skilled colleagues such as Tianming Wang and Chengxi Yang. These collaborations enhance the synergy in their research efforts, leading to groundbreaking developments in drug formulation and patient care.
Conclusion: Xing Chen's contributions to the field of pharmaceuticals through his innovative patent highlight his importance as an inventor in the realm of dihydropyrimidine compounds. His work not only advances scientific understanding but also opens new avenues for treating viral diseases, showcasing the impact of innovation in the medical field. As he continues his journey with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., the future looks promising for Chen and his ongoing contributions to healthcare and therapeutics.